#Novo Nordisk
1 article found
Anthropic CEO Dario Amodei says AI can accelerate drug discovery
Pharmaceutical companies are increasingly integrating artificial intelligence into drug discovery processes to reduce development timelines. Meanwhile, artificial intelligence firms like Anthropic are forming partnerships and seeking acquisitions in the sector.